Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Reliance Chemotex
Join Channel
Consolidated Standalone

Reliance Chemotex

₹199.7 -1.2 | 0.6%

Market Cap ₹151 Cr.

Stock P/E 27.3

P/B 1.1

Current Price ₹199.7

Book Value ₹ 176.2

Face Value 10

52W High ₹350.5

Dividend Yield 1.25%

52W Low ₹ 160.2

Edit Ratio

Reliance Chemotex Research see more...

Overview Inc. Year: 1977Industry: Textile - Spinning

Reliance Chemotex Industries Limited (RCIL) is a company that specializes in production of synthetic, blended yarns for various textile applications. It was founded by Mr. Shanker Lal Shroff in 1977 and has grown from a single spinning mill to a well-respected exporter of yarns to over 37 countries around the world. They have a diversified product portfolio that includes ecru and dyed yarns, chenille yarns, artificial leather, laminated fabrics, and suitings. It has a total production capacity of 14000+ tonnes and a total turnover of 295+ crores.They have pioneered the use of fibre-dyed polyester/viscose blended yarns and multifold viscose yarns in the Indian market. The company's corporate office is located in Mumbai and its manufacturing units are located in Udaipur, Rajasthan.

Read More..

Reliance Chemotex Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Reliance Chemotex Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 89 87 104 100 93 92 80 90 89 85
Other Income 1 1 4 1 1 3 1 1 1 1
Total Income 90 88 107 101 94 95 81 91 90 86
Total Expenditure 79 76 92 91 83 85 71 81 82 78
Operating Profit 11 12 15 10 10 10 10 10 8 8
Interest 3 4 3 3 3 3 5 5 5 5
Depreciation 2 2 2 2 2 2 3 3 3 3
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 6 6 10 4 5 5 3 3 0 1
Provision for Tax 2 2 4 1 2 2 0 1 -0 1
Profit After Tax 4 4 6 3 3 3 3 2 0 0
Adjustments 0 0 0 -0 0 0 0 -0 0 -0
Profit After Adjustments 4 4 6 3 3 3 3 2 0 0
Adjusted Earnings Per Share 5.8 5.7 8.4 4.3 4.4 4.1 3.7 3 0.6 0.1

Reliance Chemotex Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 204 250 235 257 291 285 323 300 256 362 365 344
Other Income 3 3 17 3 4 1 2 1 4 7 6 4
Total Income 208 253 252 260 295 286 325 301 260 368 371 348
Total Expenditure 186 227 224 239 269 265 298 271 233 320 331 312
Operating Profit 22 26 27 21 26 21 28 29 28 48 40 36
Interest 9 11 13 13 14 12 13 11 10 12 14 20
Depreciation 5 6 6 7 7 7 7 7 8 9 10 12
Exceptional Income / Expenses -0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 8 9 9 2 5 1 8 11 10 27 17 7
Provision for Tax 2 4 3 -1 -2 -2 4 1 3 9 4 2
Profit After Tax 6 6 7 3 6 3 4 9 7 18 12 5
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 6 6 7 3 6 3 4 9 7 18 12 5
Adjusted Earnings Per Share 11 8.4 9.9 0.5 14.5 5.8 9.2 12.4 9.2 24 16.5 7.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 7% 5% 6%
Operating Profit CAGR -17% 11% 14% 6%
PAT CAGR -33% 10% 32% 7%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 16% 30% 24% 20%
ROE Average 10% 11% 10% 12%
ROCE Average 11% 13% 13% 13%

Reliance Chemotex Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 48 53 59 59 68 70 67 98 104 121 132
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 46 43 63 51 60 52 50 29 34 47 66
Other Non-Current Liabilities 5 7 9 8 17 13 21 20 22 30 33
Total Current Liabilities 49 52 60 84 84 94 82 83 104 139 167
Total Liabilities 148 154 191 201 229 229 220 230 264 338 398
Fixed Assets 66 82 107 109 152 143 137 134 148 179 194
Other Non-Current Assets 22 7 6 3 3 5 6 18 9 23 57
Total Current Assets 60 65 78 90 74 81 77 78 107 136 148
Total Assets 148 154 191 201 229 229 220 230 264 338 398

Reliance Chemotex Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 6 5 3 4 1 1 0 0 1 0 0
Cash Flow from Operating Activities 7 17 0 12 32 11 26 22 27 59 -0
Cash Flow from Investing Activities -18 -5 -27 -6 -2 -0 -0 -8 -43 -74 -51
Cash Flow from Financing Activities 10 -14 28 -6 -30 -11 -26 -13 15 14 55
Net Cash Inflow / Outflow -1 -2 1 0 -0 -1 -0 1 -0 -0 4
Closing Cash & Cash Equivalent 5 3 4 5 1 0 0 1 0 0 4

Reliance Chemotex Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 11.04 8.36 9.92 0.5 14.48 5.82 9.16 12.37 9.19 24.04 16.46
CEPS(Rs) 25.19 25.19 27.32 20.39 30.93 22.37 24.18 22.1 19.26 35.34 29.4
DPS(Rs) 1 1 1 1 1 1 1.5 1 2 2.5 2.5
Book NAV/Share(Rs) 67.94 72.75 80.67 79.52 152.1 157.63 149.73 130.06 138.36 160.94 174.97
Core EBITDA Margin(%) 8.89 9.05 4.31 7.06 7.48 6.72 7.89 9.47 9.04 11.46 9.38
EBIT Margin(%) 8.07 7.91 9.02 5.67 6.4 4.62 6.53 7.37 7.83 10.92 8.4
Pre Tax Margin(%) 3.65 3.7 3.78 0.65 1.62 0.29 2.49 3.59 4.05 7.56 4.58
PAT Margin (%) 2.86 2.21 2.72 0.97 2.2 0.91 1.27 3.11 2.71 5.01 3.4
Cash Profit Margin (%) 5.08 4.41 5.1 3.49 4.69 3.5 3.34 5.56 5.68 7.37 6.08
ROA(%) 4.36 3.75 3.77 1.29 3.01 1.14 1.82 4.15 2.81 6.02 3.37
ROE(%) 22.72 18.4 18.96 7.06 12.5 3.75 5.96 11.31 6.85 16.06 9.8
ROCE(%) 15.92 17.24 16.59 10.17 12.15 8.07 13.49 14.19 11.01 17.68 10.67
Receivable days 20.03 20.59 23.63 23.81 24.24 22.77 19.64 18.75 17.06 8.1 6.42
Inventory Days 40.4 33.03 43.87 51.37 47.83 50.86 44.8 44.4 58.35 45.96 44.87
Payable days 43.64 38.82 60.24 75.48 75.35 83.26 69.75 74.68 70.3 48.68 40.25
PER(x) 2.5 3.24 3.73 76 4.26 11.66 7.38 3.52 8.37 9.64 9.62
Price/Book(x) 0.41 0.37 0.46 0.48 0.41 0.43 0.45 0.33 0.56 1.44 0.9
Dividend Yield(%) 3.23 3.28 2.41 2.35 1.45 1.31 1.98 2.3 2.6 1.08 1.58
EV/Net Sales(x) 0.47 0.37 0.51 0.49 0.4 0.42 0.33 0.31 0.48 0.67 0.7
EV/Core EBITDA(x) 4.3 3.62 4.37 5.83 4.47 5.82 3.88 3.14 4.41 5.03 6.29
Net Sales Growth(%) 2.49 22.33 -6.15 9.63 13.16 -2.2 13.58 -7.24 -14.73 41.52 0.86
EBIT Growth(%) 33.89 18.64 6.91 -31.38 27.35 -30.16 59.98 4.71 -9.47 97.4 -22.43
PAT Growth(%) 171.42 -6.22 15.03 -61.12 156.04 -59.91 57.5 128.07 -25.72 161.6 -31.51
EPS Growth(%) 388.28 -24.26 18.64 -94.97 2801.41 -59.83 57.5 35.03 -25.72 161.6 -31.51
Debt/Equity(x) 1.44 1.23 1.42 1.53 1.39 1.33 1.22 0.66 0.92 1.03 1.49
Current Ratio(x) 1.22 1.25 1.3 1.06 0.88 0.86 0.93 0.94 1.03 0.98 0.88
Quick Ratio(x) 0.75 0.8 0.73 0.6 0.43 0.42 0.47 0.52 0.58 0.66 0.61
Interest Cover(x) 1.82 1.88 1.72 1.13 1.34 1.07 1.61 1.95 2.07 3.25 2.2
Total Debt/Mcap(x) 6.19 5.33 5.09 5.29 3.43 3.1 2.71 1.97 1.66 0.71 1.64

Reliance Chemotex Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 67.68 67.68 67.68 67.68 67.68 67.68 67.68 67.68 67.68 67.68
FII 1.43 1.39 1.52 1.66 1.66 1.66 1.24 0 0.57 0.11
DII 0 0 0 0 0 0 0 0 1.8 0
Public 30.89 30.92 30.79 30.66 30.66 30.66 31.07 32.32 29.94 32.21
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 31% CAGR over last 5 years
  • Debtor days have improved from 48.68 to 40.25days.

Cons

  • Company has a low return on equity of 11% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Reliance Chemotex News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!